AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A Long-term Observational Study to Describe the Use of Vitamin-C Injektopas® 7.5 g in Patients With Vitamin C Deficiency

Recruitingn/aAges 18 Years - 120 YearsAllPascoe Pharmazeutische Praeparate GmbH
💬

In plain words

What the trial is, and whether it could suit you

The goal of this observational study is to learn more about the disease and the symptoms where the product will use and in which patient groups. Further on, it is interesting to know clinical pictures, the symptoms improve. Patients with acute or chronical disease with vitamin c deficiency could be involved. The main questions it aims to answer are: * how do the symptoms of the disease change * how is the tolerability

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with vitamin C deficiency * Age ≥ 18 years Exclusion Criteria: * Hypersensitivity to the active ingredient or any of the excipients * Oxalate urolithiasis * Iron storage disease (thalassemia, hemochromatosis, sideroblastic anemia) or recent red blood cell transfusion * Renal insufficiency * Glucose-6-phosphate dehydrogenase deficiency/defect * Pregnant/breastfeeding women
💊

What it tests

  • Not listed
📍

Where

1 site
Multiple Physicians from Austria
Vienna, Etc., Austria
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy